Comparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 ≤20%

Özaslan, EKoca, SSevinç, AHacioglu, BÖzçelik, MDuran, AOYildiz, YTanriverdi, ÖMenekse, SAksoy, AElmaci, SUysal, MÇiltas, A2025-04-102025-04-100028-3835http://hdl.handle.net/20.500.14701/42762EnglishComparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 ≤20%Meeting Abstract1423-0194